P-49

Dashrath Chauhan¹,², Chen Chen¹,³, Jonathan Turner¹,⁴, Stephanie Li¹,⁵, Jeremy Adams¹,³, Jimmy Payyappilly¹,², and Sasha V. Siegel¹,²

¹Global Alliance for Genomics and Health
²EMBL's European Bioinformatics Institute
³Ontario Institute for Cancer Research
⁴Wellcome Sanger Institute
⁵Broad Institute of MIT and Harvard

GA4GH Products have been in development for 12 years now. The products are diverse: standard specifications, policy frameworks, and APIs. There's a need for a strategic view of GA4GH products. This will enable strategise path forward through impactful, data-driven decisions. The dashboard creates a unified database to capture metrics from priority data sources - Europe PMC, GitHub, and PyPI. There are multiple benefits of analytics and consequently, the dashboard for decision making at GA4GH - quantify GA4GH impact for future funding opportunities; target engagement appropriately to expand the global community; identify valuable contributions from the wider GA4GH ecosystem; and create a pipeline for evidence-based decision making on product health and improvements.